Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
2.
Int J Gynecol Cancer ; 18(5): 985-95, 2008.
Article in English | MEDLINE | ID: mdl-18028381

ABSTRACT

We set out to discover ovarian cancer biomarkers useful for monitoring progression during and after chemotherapy and possibly for diagnosis. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry was used to create serum protein profiles of ovarian cancer patients before chemotherapy or at progression (n = 51) (trial initiated by the Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer trial) that were compared with those of healthy individuals (n = 31). In addition, sera profiles from ovarian cancer patients after chemotherapy (n = 12) were compared with those of ovarian cancer patients at progression (n = 24). One of the discovered biomarkers was identified and subsequently confirmed and validated using enzyme-linked immunosorbent assay (ELISA). Eight primary (sens = 94%, spec = 97%, P < 0.0001) and seven progression tumor biomarkers (sens = 91%, spec = 97%, P < 0.0001) were discovered. In addition, we discovered eight potential progression monitoring biomarkers (sens = 75%, spec = 83%, P = 0.0008) of which one, a biomarker of 11.7 kd, was further identified as serum amyloid A1. Independent validation (ELISA) showed an elevated expression of this protein at relapse in four of the seven ovarian cancer patients tested. Combining the eight newly discovered progression monitoring biomarkers with CA125 resulted in a clear increase of the sensitivity (91-100%). These biomarkers, in combination with for instance CA125, should be validated in large ovarian cancer and control groups. The resulting multimarker assay could be suitable for disease monitoring during and after therapy and might also be useful for ovarian cancer screening.


Subject(s)
Biomarkers, Tumor/blood , Ovarian Neoplasms/blood , Adult , Aged , Biomarkers, Tumor/chemistry , Biomarkers, Tumor/immunology , Biomarkers, Tumor/isolation & purification , Enzyme-Linked Immunosorbent Assay , Female , Health , Humans , Mass Spectrometry , Middle Aged , Ovarian Neoplasms/pathology , Ovarian Neoplasms/therapy , Prognosis , Proteomics
3.
Amino Acids ; 25(3-4): 397-407, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14661099

ABSTRACT

Oxidatively modified proteins have been shown to correlate with the age of an organism or its tissues. An increase in tissue-susceptibility to experimentally induced protein oxidation not only depends on tissue type and age, but also on the maximum lifespan potential of the species. A general, although tissue dependent, decline in anti-oxidative defenses during aging may very well be responsible for this difference in vulnerability. In addition, the level of protein modifications also depends on the nature and the subcellular localization of the proteins involved. Damage to the endoplasmic reticulum (ER), and its subsequent impaired functionality may be involved in the process of aging. This is suggested by; (1) an upregulation of ER stress-response chaperones, (2) a preferential oxidation of ER-resident proteins and, (3) a disturbance of calcium homeostasis. Therefore, this review will focus on the putative involvement of the oxidized endoplasmic reticulum in the process of aging.


Subject(s)
Aging/metabolism , Endoplasmic Reticulum/metabolism , Proteins/metabolism , Aging/physiology , Animals , Endoplasmic Reticulum/chemistry , Glutathione/metabolism , Humans , Models, Biological , Oxidation-Reduction , Protein Folding
4.
Biochemistry ; 40(26): 7783-8, 2001 Jul 03.
Article in English | MEDLINE | ID: mdl-11425304

ABSTRACT

Oxidative damage to proteins has been postulated as a major cause of various degenerative diseases including the loss of functional capacity during aging. A prominent target for oxidation by reactive oxygen species (ROS) is the tyrosine residue. Here we present a highly sensitive method for the detection of tyrosyl radical formation in cells. The method is based on the fluorescein-labeled tyrosine analogue, tyramine, which upon oxidation may couple to proteins carrying a tyrosyl radical. Coupling of the probe (denoted TyrFluo) to standard proteins could be induced by generating ROS with horseradish peroxidase/hydrogen peroxide, SIN-1 or with peroxides (cumene or hydrogen peroxide) in combination with a transition metal. TyrFluo added to rat-1 fibroblasts remained outside the cell, whereas the acetylated form (acetylTyrFluo) was membrane-permeable and accumulated in the cell. Exposure of the cells to oxidative stress in the presence of either TyrFluo or acetylTyrFluo gave a cellular labeling characteristic for each probe. Western blot analysis confirmed that each probe labeled a specific set of proteins. This new method for the detection of ROS-induced oxidation of proteins may mimic the tendency of oxidized proteins to form dityrosine bonds.


Subject(s)
Fibroblasts/metabolism , Fluorescent Dyes/metabolism , Proteins/metabolism , Tyramine/metabolism , Acetylation , Animals , Cell Line , Cell Membrane Permeability , Cross-Linking Reagents/metabolism , Fluorescein/metabolism , Fluoresceins/metabolism , Free Radicals/metabolism , Microscopy, Fluorescence , Oxidation-Reduction , Rats , Reactive Oxygen Species/metabolism , Tyrosine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL